Kinase inhibitors

Details Kinase inhibitors Kinase inhibitors

2006-07-11

2006-07-11

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S206000, C544S207000, C544S208000, C544S209000, C544S210000, C544S219000

Reexamination Certificate

active

07074789

ABSTRACT:
The invention relates to inhibitors of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds, methods of inhibiting phosphoryl transferase activity, and methods for treating disease or disease symptoms.

REFERENCES:
patent: 2474194 (1949-06-01), Thurston et al.
patent: 3136816 (1964-06-01), Cutler et al.
patent: 4983608 (1991-01-01), Effland et al.
patent: 5043317 (1991-08-01), Chapman et al.
patent: 5215569 (1993-06-01), Drewes et al.
patent: 5869030 (1999-02-01), Dumler et al.
patent: 5935966 (1999-08-01), Suto et al.
patent: 5958935 (1999-09-01), Davis et al.
patent: 6080858 (2000-06-01), Schumacher
patent: 261812 (1949-09-01), None
patent: 0 002 341 (1979-06-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 945 443 (1999-09-01), None
patent: 1 040 831 (2000-04-01), None
patent: 1390235 (1975-04-01), None
patent: WO 94/26733 (1994-11-01), None
patent: WO 95/33750 (1995-12-01), None
patent: WO 96/05177 (1996-02-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 98/18782 (1998-05-01), None
patent: WO 99/01136 (1999-01-01), None
patent: WO 99/31073 (1999-06-01), None
patent: WO 99/31121 (1999-06-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 99/50250 (1999-10-01), None
patent: WO 99/65909 (1999-12-01), None
patent: WO 00/12485 (2000-03-01), None
patent: WO 00/27825 (2000-05-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/43373 (2000-07-01), None
patent: WO 00/53595 (2000-09-01), None
patent: WO 00/59892 (2000-10-01), None
patent: WO 00/63204 (2000-10-01), None
patent: WO 00/78731 (2000-12-01), None
patent: WO 01/00213 (2001-01-01), None
patent: WO 01/22938 (2001-04-01), None
patent: WO 01/29009 (2001-04-01), None
patent: WO 01/40218 (2001-06-01), None
Shapiro, et al.,Guanamine Diuretics, Journal of the American Chemical Society, American Chemical Society, Washington DC, US, XP-002110860, vol. 79, 5064-5071 (1957).
Arteaga et al. “HER(erbB)Tyrosine Kinase Inhibitors in the Treatment of Breast Cancer” Seminars in Oncology 29(No. 2 Suppl. 11) 4-10 (2002).
Bolen et al., “Leukocyte Protein Tyrosine Kinases: Potential Targets for Drug Discovery” Annu. Rev. Immunology 15:371-404 (1997).
Cao et al., “Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor(HGF/SF)display antitumor activity in animal models” PNAS (Proceedings of the National Academy of Sciences of the United States of America) 98:13 7443-7448.
Khandwala et al. “The effects of Insulin-like growth factors on Tumorigenesis and Neoplastic Growth” Endocrine Reviews 21(3):215-244 (2000).
Muller et al., “Expression of angiopoietin-1 and its receptor TEK in hematopoietic cells from patients with myeloid leukemia” Leukemia Research 26:163-168 (2002).
Raymond et al., “Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy” Drugs 60 Suppl.1: 15-23 (2000).
Scheijen et al. “Tyrosine kinase oncogenes in normal hematopoiesis and hemtological disease” Oncogene 21: 3314-3333 (2002).
Sweeney et al., “Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor” Kidney International, 57:33-40 (2000).

Affiliated with

Also associated with

Rating

Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3547675